A new study finds combining bimagrumab with Wegovy leads to significant fat loss without muscle loss. This breakthrough ...

The combination offers a potential solution to one of the key problems that’s emerged with popular obesity shots.

Eli Lilly's bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, ...

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Trial finds weight loss drug taken monthly helps people lose 20% of body weight – but adverse GI events were ‘common’ - The ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

In combination with Eli Lilly’s tirzepatide, marketed as Zepbound for obesity, Scholar Rock’s monolonal antibody helped ...

Scientists created a new weight-loss drug that protects blood sugar levels and muscle mass. The new weight-loss tablet was ...

Ultimately, 274,182 patients were part of the study, which has not yet been published. Although weight loss was low in the ... PharmaVentures, Pfizer, Regeneron, Roche, Sanofi, Shionogi, Source ...